ArticleJournal of neuroinflammation2025

Rebamipide (Mucosta®), a clinically approved drug, alleviates neuroinflammation and dopaminergic neurodegeneration in a Parkinson's disease model.

Hye-Sun Lim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.